Clinical Trial Update: Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the safety and efficacy of sunitinib malate in Chinese patients with imatinib-resistant or intolerant malignant gastrointesti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neoplasms
• Gastrointestinal Stromal Tumor

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors | Phase 4 | Status: COMPLETED | Results posted: 2015-05-01